JNJ

227.58

+1.12%↑

ABT

93.81

+1.03%↑

MDT

81.87

-1.27%↓

A

114.85

-0.62%↓

VEEV

158.41

-1.09%↓

JNJ

227.58

+1.12%↑

ABT

93.81

+1.03%↑

MDT

81.87

-1.27%↓

A

114.85

-0.62%↓

VEEV

158.41

-1.09%↓

JNJ

227.58

+1.12%↑

ABT

93.81

+1.03%↑

MDT

81.87

-1.27%↓

A

114.85

-0.62%↓

VEEV

158.41

-1.09%↓

JNJ

227.58

+1.12%↑

ABT

93.81

+1.03%↑

MDT

81.87

-1.27%↓

A

114.85

-0.62%↓

VEEV

158.41

-1.09%↓

JNJ

227.58

+1.12%↑

ABT

93.81

+1.03%↑

MDT

81.87

-1.27%↓

A

114.85

-0.62%↓

VEEV

158.41

-1.09%↓

Search

Integra LifeSciences Holdings Corp

Fechado

SetorSaúde

10.7 0.28

Visão Geral

Variação de preço das ações

24h

Atual

Mín

10.42

Máximo

10.86

Indicadores-chave

By Trading Economics

Rendimento

3.7M

-1.7M

Vendas

33M

435M

Margem de lucro

-0.392

Funcionários

4,427

EBITDA

12M

66M

Recomendações

By TipRanks

Recomendações

Vender

Previsão para 12 meses

+2.9% upside

Dividendos

By Dow Jones

Próximos Ganhos

5 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-46M

870M

Abertura anterior

10.42

Fecho anterior

10.7

Sentimento de Notícias

By Acuity

50%

50%

157 / 348 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

27 de abr. de 2026, 23:15 UTC

Notícias Principais

U.K. Consumers Pay Less But Full Impact of Mideast War to Be Seen

27 de abr. de 2026, 23:08 UTC

Ganhos
Grandes Movimentos do Mercado

LendingClub Shares Gain on 1Q Profit, Revenue Beat

27 de abr. de 2026, 23:58 UTC

Ganhos

Samsung SDI 1Q Net Profit Beat FactSet-Compiled Consensus

27 de abr. de 2026, 23:58 UTC

Ganhos

Samsung SDI 1Q Net KRW56.10B Vs. Loss KRW216.00B >006400.SE

27 de abr. de 2026, 23:56 UTC

Ganhos

Samsung SDI 1Q Oper Loss KRW155.60B Vs. Loss KRW434.10B >006400.SE

27 de abr. de 2026, 23:56 UTC

Ganhos

Samsung SDI 1Q Rev KRW3.576T Vs. KRW3.177T >006400.SE

27 de abr. de 2026, 23:48 UTC

Conversa de Mercado

Nikkei May Remain Rangebound Amid Uncertainty Over Iran Conflict -- Market Talk

27 de abr. de 2026, 23:42 UTC

Conversa de Mercado

Australian Consumer Confidence Making a Slow Come Back -- Market Talk

27 de abr. de 2026, 23:34 UTC

Conversa de Mercado
Notícias Principais

Gold Edges Higher as Investors Assess Iran's Proposal to U.S. -- Market Talk

27 de abr. de 2026, 23:30 UTC

Conversa de Mercado

Australia's NDIS Could Lose 'Social Licence' If Not Reined In -- Market Talk

27 de abr. de 2026, 23:08 UTC

Conversa de Mercado

Polymetals's Revenue Outlook 'Extraordinary' for a Small-Cap Stock -- Market Talk

27 de abr. de 2026, 23:02 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

27 de abr. de 2026, 23:02 UTC

Conversa de Mercado

Warsh Will Probably Lean a Bit More Dovish Than Powell -- Market Talk

27 de abr. de 2026, 22:42 UTC

Conversa de Mercado

BOJ Expected to Keep Rates On Hold; Guidance to Skew Hawkish -- Market Talk

27 de abr. de 2026, 22:10 UTC

Ganhos

Haier Smart Home: Results Also Weighed by Weak Demand in China-U.S. Markets >600690.SH

27 de abr. de 2026, 22:09 UTC

Ganhos

Haier Smart Home: Increase in Tariff Costs, Extreme Weather Conditions Hurt Results >600690.SH

27 de abr. de 2026, 22:09 UTC

Ganhos

Haier Smart Home 1Q Net CNY4.65B Vs. Net CNY5.49B >600690.SH

27 de abr. de 2026, 22:09 UTC

Ganhos

Haier Smart Home 1Q Rev CNY73.69B Vs. CNY79.12B >600690.SH

27 de abr. de 2026, 21:56 UTC

Ganhos

Tsingtao Brewery: Cost Controls Among Factors Supporting Results >0168.HK

27 de abr. de 2026, 21:55 UTC

Ganhos

Tsingtao Brewery 1Q Net CNY1.80B Vs. Net CNY1.71B >0168.HK

27 de abr. de 2026, 21:55 UTC

Ganhos

Tsingtao Brewery 1Q Rev CNY10.29B Vs. CNY10.45B >0168.HK

27 de abr. de 2026, 21:44 UTC

Ganhos

Tianqi Lithium: Higher Demand for Products From EV Sector Also Boosted Financial Performance >002466.SZ

27 de abr. de 2026, 21:43 UTC

Ganhos

Tianqi Lithium: Increase in Average Selling Prices of Major Lithium Products Supported Results >002466.SZ

27 de abr. de 2026, 21:41 UTC

Ganhos

Tianqi Lithium 1Q Rev CNY5.13B Vs. CNY2.58B >002466.SZ

27 de abr. de 2026, 21:41 UTC

Ganhos

Tianqi Lithium 1Q Net CNY1.88B Vs. Net CNY104.27M >002466.SZ

27 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

27 de abr. de 2026, 20:50 UTC

Conversa de Mercado
Notícias Principais

Basic Materials Roundup: Market Talk

27 de abr. de 2026, 20:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Financial Services Roundup: Market Talk

27 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

27 de abr. de 2026, 20:39 UTC

Ganhos

Nucor: Operating Segments Earnings Growth Driven by Trade Policies That Continue to Reduce Flood of Unfairly Traded Imports Into U.S. >NUE

Comparação entre Pares

Variação de preço

Integra LifeSciences Holdings Corp Previsão

Preço-alvo

By TipRanks

2.9% parte superior

Previsão para 12 meses

Média 11 USD  2.9%

Máximo 12 USD

Mínimo 9 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Integra LifeSciences Holdings Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Vender

6 ratings

0

Comprar

4

Manter

2

Vender

Pontuação Técnica

By Trading Central

12.75 / 16.41Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Weak Bearish Evidence

Sentimento

By Acuity

157 / 348 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat